David Shultz

9PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseasesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 26, 2026
Risk prediction model for brain metastasis risk among patients diagnosed with primary gastrointestinal cancers.

|Jun 04, 2026
Detecting ctDNA Using Personalized Structural Variants to Forecast Recurrence in Localized Soft-Tissue Sarcoma.

|Jul 27, 2025
Cumulative incidence and survival outcomes of brain metastases in sarcoma: a large single center retrospective analysis.

Ayah Erjan, Kurl Jamora, Enrique Gutierrez

|Oct 24, 2023
Radiomic-Based Prediction of Lesion-Specific Systemic Treatment Response in Metastatic Disease.

Caryn Geady, Farnoosh Abbas-Aghababazadeh, Andres Kohan

|Mar 27, 2023
Review of 20 years of adult medulloblastoma treatment: Chemotherapy prescription trends and survival.

Marissa Sherwood, Seth Climans, Ronald Ramos

|Jan 28, 2022
Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer.

Annemarie C Eggen, Nadine M Richard, Ingeborg Bosma

Pageof 2

Frequent Collaborators

2 joint publications

Fabio Y Moraes

2 joint publications

David Kirsch

2 joint publications

Ayah Erjan

1 joint publications

A Dasgupta